Literature DB >> 12842639

Electrocardiographic pattern of Brugada syndrome disclosed by a febrile illness: clinical and therapeutic implications.

N Patruno1, D Pontillo, A Achilli, G Ruggeri, G Critelli.   

Abstract

BACKGROUND: Recent studies have identified a direct link between the ionic mechanisms responsible for the electrocardiographic (ECG) pattern of the Brugada syndrome (BS) and the in vitro experimental temperature, pointing to the possibility that some BS patients may display the ECG phenotype only during a febrile state, being in this setting at risk of lethal arrhythmias. CASE REPORT: A 53-year-old man referred to the emergency room for abdominal pain and fever. The ECG showed dome-shaped ST-segment elevation in V1-V3, as in the typical BS. The personal and family history were unremarkable for syncope and sudden death and physical, laboratory and ultrasound examinations were negative. On day 3, at normal body temperature, the patient's ECG returned to normal and the ECG abnormalities were later reproduced with intravenous flecainide. The patient refused the implantation of a loop recorder and was discharged after 6 days. He has remained asymptomatic during 2 years of follow-up.
CONCLUSIONS: The typical ECG phenotype of BS disclosed by a febrile illness confirms the in vitro experimental data that previously established a correlation between ECG pattern of BS and temperature variations. The clinical and therapeutic implications of these findings are discussed.

Entities:  

Mesh:

Year:  2003        PMID: 12842639     DOI: 10.1016/s1099-5129(03)00029-1

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  10 in total

1.  How can a single mutation cause such arrhythmic havoc?

Authors:  Isabelle Deschênes; Kenneth R Laurita
Journal:  Heart Rhythm       Date:  2006-11-17       Impact factor: 6.343

Review 2.  Drug-induced spatial dispersion of repolarization.

Authors:  Charles Antzelevitch
Journal:  Cardiol J       Date:  2008       Impact factor: 2.737

3.  A novel SCN5A mutation V1340I in Brugada syndrome augmenting arrhythmias during febrile illness.

Authors:  Kaveh Samani; Geru Wu; Tomohiko Ai; Mossaab Shuraih; Nilesh S Mathuria; Zhaohui Li; Yoshiro Sohma; Enkhsaikhan Purevjav; Yutao Xi; Jeffrey A Towbin; Jie Cheng; Matteo Vatta
Journal:  Heart Rhythm       Date:  2009-05-18       Impact factor: 6.343

4.  Fever-triggered ventricular arrhythmias in Brugada syndrome and type 2 long-QT syndrome.

Authors:  A S Amin; C A Klemens; A O Verkerk; P G Meregalli; A Asghari-Roodsari; J M T de Bakker; C T January; A A M Wilde; H L Tan
Journal:  Neth Heart J       Date:  2010-03       Impact factor: 2.380

5.  Electrocardiographic findings compatible with Brugada syndrome in a patient with febrile respiratory infection.

Authors:  K Tsarouhas; P Papalexis; I Kafantaris; Ch Tsitsimpikou; S Vavetsi; E Rentoukas
Journal:  Hippokratia       Date:  2010-07       Impact factor: 0.471

Review 6.  Brugada syndrome.

Authors:  Charles Antzelevitch
Journal:  Pacing Clin Electrophysiol       Date:  2006-10       Impact factor: 1.976

Review 7.  Brugada pattern: a comprehensive review on the demographic and clinical spectrum.

Authors:  Hassan Abbas; Sohaib Roomi; Waqas Ullah; Asrar Ahmad; Ganesh Gajanan
Journal:  BMJ Case Rep       Date:  2019-07-11

8.  Concomitant Brugada-like and short QT electrocardiogram linked to SCN5A mutation.

Authors:  Kui Hong; Jinzhu Hu; Jianhua Yu; Ramon Brugada
Journal:  Eur J Hum Genet       Date:  2012-04-11       Impact factor: 4.246

Review 9.  Cardiovascular Complications of Chimeric Antigen Receptor T-Cell Therapy: The Cytokine Release Syndrome and Associated Arrhythmias.

Authors:  Cesar Clavijo Simbaqueba; Maria Patarroyo Aponte; Peter Kim; Anita Deswal; Nicolas L Palaskas; Cezar Iliescu; Eiman Jahangir; Eric H Yang; Raphael E Steiner; Juan Lopez-Mattei
Journal:  J Immunother Precis Oncol       Date:  2020-07-20

10.  May fever trigger ventricular fibrillation?

Authors:  Jean Luc Pasquié
Journal:  Indian Pacing Electrophysiol J       Date:  2005-04-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.